Sue Gail Eckhardt, who serves as a director at Exelixis, Inc. (NASDAQ:EXEL), conducted a transaction involving the sale of company stock on June 1, 2026. Specifically, Ms. Eckhardt sold 9,812 shares of the firm's common stock, totaling $491,973 in value.
The details of the sale indicate that the individual shares were purchased at varying prices, ranging from $49.73 to $50.61 per share. The weighted average selling price for these units was determined to be $50.14. Notably, this transaction was structured and executed under a Rule 10b5-1 trading plan, a mechanism that Ms. Eckhardt adopted previously on November 11, 2025.
This reported insider activity takes place while Exelixis stock is currently trading near its 52-week high of $52.96, with the share price observed at $51.61. From a valuation standpoint, some analysis suggests that the stock may be undervalued at current levels, citing a Fair Value suggestion that implies potential upside for investors. The company maintains an